Clinical Trial Results

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

PHASE4INTERVENTIONAL Glendale, Arizona +4 more

RECRUITING

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

N/AOBSERVATIONAL La Jolla, California +4 more

RECRUITING

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

PHASE3INTERVENTIONAL Los Angeles, California +4 more

RECRUITING

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

PHASE1INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

PHASE2INTERVENTIONAL San Francisco, California +4 more

RECRUITING

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

PHASE3INTERVENTIONAL Los Angeles, California +4 more

RECRUITING

Lupus Landmark Study: A Prospective Registry and Biorepository

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

PHASE1, PHASE2INTERVENTIONAL Orange, California +4 more

RECRUITING

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

PHASE2INTERVENTIONAL Loma Linda, California +4 more

RECRUITING

Wellness & Workforce Solution for Lupus/Lupus Nephritis

NAINTERVENTIONAL Atlanta, Georgia

RECRUITING

VIBRANT: VIB4920 for Active Lupus Nephritis

PHASE2INTERVENTIONAL La Jolla, California +4 more

RECRUITING

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

PHASE1, PHASE2INTERVENTIONAL Little Rock, Arkansas +4 more

RECRUITING

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

PHASE1, PHASE2INTERVENTIONAL San Francisco, California +4 more

RECRUITING

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

PHASE3INTERVENTIONAL Beverly Hills, California +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

PHASE3INTERVENTIONAL Avondale, Arizona +4 more

RECRUITING

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

PHASE4INTERVENTIONAL La Mesa, California +4 more

RECRUITING

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

PHASE3INTERVENTIONAL Anniston, Alabama +4 more

RECRUITING

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

PHASE2INTERVENTIONAL Hollywood, Florida +3 more

RECRUITING